Recipient of federal assistance · NORTH PALM BEACH, FL

AQUALUNG THERAPEUTICS, CORP

AQUALUNG THERAPEUTICS, CORP received -$301.2K in federal grants and other assistance in FY2026, on 4 actions. It has no federal contracts in the loaded years. Since FY2021: $9.5M.

Assistance · FY2026
-$301.2K
New awards
0
Actions
4
Since FY2021
$9.5M
UEI
MKDKZ3ZZ99A2
Location
NORTH PALM BEACH, FL
Businesses
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 1.8MFY2021
  2. 1.8MFY2022
  3. 3.3MFY2023
  4. 3.3MFY2024
  5. -257.7KFY2025
  6. -301.2KFY2026

By type

  1. Grants-$301.2K0.0%

Top programs · Awarding agencies

Obligations in FY2026.

Top programs

  1. 93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research-$97.7K0.0%
  2. 93.837 · Cardiovascular Diseases Research-$203.5K0.0%

Largest awards

  1. A RANDOMIZED PHASE 2A CLINICAL TRIAL PIONEERING THE UTILITY OF AN ENAMPT-REDUCING THERAPY IN ARDS/VILI: THE PUERTA TRIAL - ABSTRACT THE…$2.3M
    93.837 · Cardiovascular Diseases Research· National Institutes of Health· Project grant· Sep 8, 2023 – Mar 20, 2026· R44HL145930
  2. TARGETING THE ENAMPT/TLR4 PATHWAY TO REDUCE INFLAMMATORY BOWEL DISEASE SEVERITY - ABSTRACT INFLAMMATORY BOWEL DISEASE (IBD) IS A…$2.1M
    93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research· National Institutes of Health· Project grant· Sep 19, 2022 – Dec 10, 2025· R42DK135208
  3. PRECLINICAL DEVELOPMENT OF A NOVEL ENAMPT-NEUTRALIZING MAB FOR PULMONARY HYPERTENSION - ABSTRACT PULMONARY ARTERIAL HYPERTENSION (PAH) IS A…$1.9M
    93.837 · Cardiovascular Diseases Research· National Institutes of Health· Project grant· Aug 29, 2022 – May 15, 2026· R42HL164300
  4. TARGETING ENAMPT-TLR4 SIGNALING WITH THE NOVEL ALT-100 MAB TO SLOW IPF PROGRESSION - ABSTRACT: THERE IS A MAJOR UNMET NEED TO IDENTIFY…$284.7K
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Sep 17, 2025 – Jan 30, 2026· R41HL180035

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2021–FY2026.